New shot could replace IV drips for nerve disease

NCT ID NCT06637072

Summary

This study is testing if adults with a chronic nerve disease called CIDP can safely switch from their current intravenous (IV) treatment to a newer medication given as a shot under the skin. The goal is to see if patients can successfully make the switch and continue the new treatment for 12 weeks. Researchers will also track side effects and how patients feel about the new treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cedar Health Research - Dallas

    Dallas, Texas, 75251, United States

  • Erlanger Neuroscience Institute

    Chattanooga, Tennessee, 37403, United States

  • Horizon Clinical Research: Gill Neuroscience

    Cypress, Texas, 21216, United States

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • National Neuromuscular Research Institute

    Austin, Texas, 78759, United States

  • Neurology Associates PA

    Maitland, Florida, 32751, United States

  • Northwest Houston Neurology - Cypress

    Cypress, Texas, 77429, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611, United States

  • SRI International - ClinEdge

    Plymouth, Michigan, 48170, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Velocity Clinical Research

    Lafayette, Louisiana, 70508, United States

  • Velocity Clinical Research

    Raleigh, North Carolina, 27607, United States

  • Visionary Investigators Network

    Miami, Florida, 33180, United States

Conditions

Explore the condition pages connected to this study.